Throughout the summer, Fresenius Kabi interns have immersed themselves in learning, developing their skills, and sharing their unique perspectives to support our mission. To celebrate their hard work and foster camaraderie, interns from our Lake Zurich and Melrose Park, IL locations recently enjoyed an afternoon of teambuilding and bowling at Pinstripes. Thank you to each of our interns for their contributions, enthusiasm, and for making this summer truly impactful! #FreseniusKabi #Interns #Teambuilding #Internship
Fresenius Kabi USA
Pharmaceutical Manufacturing
Lake Zurich, Illinois 41,204 followers
About us
Fresenius Kabi is a global healthcare company with broad capabilities in Pharma, Nutrition, MedTech, and BioPharma and deep specialization in the essential products medical professionals depend on to provide lifesaving and life-sustaining care to patients with critical and chronic conditions. The vast majority of these are used by clinicians in acute care hospitals, infusion centers, oncology clinics, and similar care sites — but a significant number support specialized activities in facilities like R&D labs and blood and plasma centers. Worldwide, Fresenius Kabi operates in more than 70 locations in 50 countries. Its corporate headquarters is in Bad Homburg, Germany. Its US headquarters is in Lake Zurich, Illinois. In the US, Fresenius Kabi offers leading portfolios in the following sub-categories: 𝐏𝐡𝐚𝐫𝐦𝐚: Injectable Medicines (Oncology, Anesthesia & Analgesia, Anti-Infectives, Critical Care) and IV Solutions 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧: Parenteral Nutrition 𝐌𝐞𝐝𝐓𝐞𝐜𝐡: Infusion Technologies, Blood Technologies, Cell & Gene Technologies, and Plasma Technologies 𝐁𝐢𝐨𝐏𝐡𝐚𝐫𝐦𝐚: Biosimilars (Oncology and Immunology)
- Website
-
http://www.fresenius-kabi.com/us
External link for Fresenius Kabi USA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Lake Zurich, Illinois
- Type
- Public Company
- Specialties
- Pharmaceuticals, Medical Devices, Generic Injectable Pharmaceuticals, Marketing, Manufacturing, Research and Development, and Biosimilars
Locations
Employees at Fresenius Kabi USA
Updates
-
Today, we celebrate the independence and freedom that define our nation. Happy 4th of July from all of us at Fresenius Kabi USA! #FourthOfJuly #IndependenceDay #USA
-
Our latest “RFID Insights” guest article features an overview of RFID healthcare workflows with Karl Hoelper, Director of Smart Packaging and New Product Innovation, CCL Healthcare. Karl shares his thoughts on RFID technology’s promising future in the healthcare setting. To read the article and subscribe, visit https://lnkd.in/emnUDTmh #RFID #FreseniusKabi #Healthcare
-
BREAKING: Fresenius Kabi has announced the immediate availability in the U.S. of its tocilizumab biosimilar in a subcutaneous formulation, in a prefilled syringe and autoinjector. “Introducing a subcutaneous formulation demonstrates our continued commitment to providing greater access to more patients living with autoimmune diseases,” said Sang-Jin Dr. Pak, President of Biopharma at Fresenius Kabi. Read the news release: https://lnkd.in/euqxHqAn #FutureFresenius #CommittedToLife #Biosimilars #Immunology
-
Thank you to everyone who connected with us at ISBT Barcelona 2024 and to all who participated in our Industry Symposium. We thoroughly enjoyed the opportunity to discuss the latest trends in blood banking, and are already looking forward to the next event! To learn more about our team and offerings, visit https://lnkd.in/egEedZ74. #FreseniusKabi #BloodBanking #ISBTBarcelona
-
Our Alliance of Asian and Pacific Islanders Employee Impact Group recently collaborated to create "senbazuru," which translates to 1,000 cranes in Japanese. These cranes symbolize hope, healing, and love, resonating with the Advocate Lutheran General Hospital Cancer Survivorship Center's mission to provide comprehensive support for patients, family members, and caregivers throughout their journey. “As a health care company our purpose is to develop medicines and technologies that serve patients,” said Saleem Farooqui, Executive Vice President at Fresenius Kabi and co-executive sponsor of the company’s AAPI EIG. “At the same time, we are all patients or caregivers ourselves and we know that inspiration and hope are sometimes needed for a patient’s journey. We want these beautiful cranes to play a role in inspiring and providing hope for those patients.” In addition to the artwork, Fresenius Kabi donated $15,000 toward supporting programing at the center, plus an additional $10,000 commitment over the next two years. Watch the video and read the Advocate Health Care blog to learn more about this culturally meaningful dedication: https://lnkd.in/ewZWbKxM
-
Join Fresenius Kabi Medical Affairs today at the ATOPP Summit for our Satellite Symposium! Dr. Andre Harvin, Chief Pharmacy Officer and VP of Pharmacy Services at Cone Health, will explore the current and future state of biosimilars in U.S. healthcare. Don't miss this insightful session! #Biosimilars #FreseniusKabi #ATOPPsummit
-
2023 Fresenius Kabi research shows that Directors of Pharmacy identify drug shortages as the top issue that their institution is facing. As a manufacturer of essential medicines, we share their concerns, have made significant investments in the U.S. and are at the forefront of legislation and solutions that work to resolve the issue of drug shortages – paving a path forward where every patient has access to the medication and care that they need. Find out what we’re doing to bring #MoreSupply to America: https://lnkd.in/e79iJiZu #EndDrugShortages #MoreInAmerica
-
Dive into the future of at-home clinical nutrition at The Oley Foundation Annual Consumer Conference. Visit our booth to learn about our patient-focused nutrition solutions and learn how we can advocate, educate, and innovate together. #FreseniusKabiNutrition #FreseniusKabi #ParenteralNutrition #ClinicalNutrition